TOKYO -- Japanese trading house Sumitomo Corp. is partnering with U.S. nuclear fusion startup Shine Technologies to enter the Asian cancer treatment field, using the American company's strengths ...

This collaboration will focus on establishing reliable supply chains for SHINE's portfolio of products and services, including critical medical isotopes like lutetium-177 and molybdenum-99 ...

"This strategic partnership with SCOA opens vital channels to bring our fusion-based technologies ... of Energy Innovation Initiative Americas at Sumitomo Corporation of Americas.